The corticolimbic structural covariance network as an early predictive biosignature for cognitive impairment in Parkinson's disease
Abstract Structural covariance assesses similarities in gray matter between brain regions and can be applied to study networks of the brain. In this study, we explored correlations between structural covariance networks (SCNs) and cognitive impairment in Parkinson’s disease patients. 101 PD patients...
Guardado en:
Autores principales: | Yueh-Sheng Chen, Hsiu-Ling Chen, Cheng-Hsien Lu, Chih-Ying Lee, Kun-Hsien Chou, Meng-Hsiang Chen, Chiun-Chieh Yu, Yun-Ru Lai, Pi-Ling Chiang, Wei-Che Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d17494e599f42f5998bafd8b4d87ca9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.
por: Judith A Potashkin, et al.
Publicado: (2012) -
Identifying molecules as biosignatures with assembly theory and mass spectrometry
por: Stuart M. Marshall, et al.
Publicado: (2021) -
Silica deposits on Mars with features resembling hot spring biosignatures at El Tatio in Chile
por: Steven W. Ruff, et al.
Publicado: (2016) -
Acute Effects of Vibration Foam Rolling with Light and Moderate Pressure on Blood Pressure and Senior Fitness Test in Older Women
por: Wen-Chieh Yang, et al.
Publicado: (2021) -
Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson’s disease
por: Hsin-Hsi Tsai, et al.
Publicado: (2021)